Jiangsu Gdk Biological Technology Co., Ltd (SHA:688670)

SHA:688670 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	62.93	84.19	83.42	70.44	174.73	36.69
Short-Term Investments	-	-	153.55	361.95	-	-
Trading Asset Securities	127.5	109.05	195.39	175.42	390.57	657.31
Cash & Short-Term Investments	190.43	193.25	432.37	607.82	565.3	694
Cash Growth	-43.46%	-55.31%	-28.87%	7.52%	-18.55%	442.13%
Accounts Receivable	70.85	139.74	112.96	81.24	341.11	342.76
Other Receivables	0.47	0.48	0.5	0.48	0.54	0.89
Receivables	71.32	140.22	113.45	81.71	341.65	343.65
Inventory	38.61	16.33	34.93	21.98	31.95	27.98
Other Current Assets	5.71	5.86	1.83	10.74	12.11	4.08
Total Current Assets	306.07	355.66	582.58	722.24	951.02	1,070
Property, Plant & Equipment	800.12	813.3	809.46	794.95	785.9	523.89
Long-Term Investments	57.29	92.87	-	-	-	-
Other Intangible Assets	31.26	30.1	30.22	35.32	40.41	45.46
Long-Term Deferred Tax Assets	74.5	74.5	55.81	33.31	17.75	21.79
Long-Term Deferred Charges	51.73	52.14	51.36	42.42	27.81	15.46
Other Long-Term Assets	0.02	0.05	3.48	3.36	3.89	78.19
Total Assets	1,321	1,419	1,533	1,632	1,827	1,754

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	54.26	19.38	25.06	11.48	9.66	7.52
Accrued Expenses	6.72	85.46	62.7	62.87	144.52	132.36
Short-Term Debt	75.05	68.05	47.63	64.06	42.04	10.01
Current Portion of Long-Term Debt	3	2	-	-	-	-
Current Income Taxes Payable	0.73	-	-	-	-	-
Current Unearned Revenue	-	-	-	-	0.05	0.05
Other Current Liabilities	54.58	66.77	75.49	88.93	106.23	71.73
Total Current Liabilities	194.34	241.66	210.88	227.34	302.5	221.68
Long-Term Debt	46	28.01	-	-	-	-
Long-Term Unearned Revenue	24.6	25.12	25.11	25.56	25.98	25.67
Long-Term Deferred Tax Liabilities	0.02	0.03	0.09	0.06	0.09	0.35
Other Long-Term Liabilities	7.98	24.68	19.25	7.56	38.54	45.42
Total Liabilities	272.94	319.5	255.33	260.52	367.11	293.12

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	123.2	123.2	123.2	123.2	88	88
Additional Paid-In Capital	1,116	1,116	1,116	1,116	1,151	1,151
Retained Earnings	-191.36	-140.29	38.18	131.68	220.27	222.73
Shareholders' Equity	1,048	1,099	1,278	1,371	1,460	1,461
Total Liabilities & Equity	1,321	1,419	1,533	1,632	1,827	1,754

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	124.05	98.05	47.63	64.06	42.04	10.01
Net Cash (Debt)	66.38	95.19	384.74	543.76	523.26	683.99
Net Cash Growth	-76.22%	-75.26%	-29.24%	3.92%	-23.50%	-
Net Cash Per Share	0.54	0.77	3.12	4.44	4.28	6.52
Filing Date Shares Outstanding	124.75	123.2	123.2	123.2	123.2	123.2
Total Common Shares Outstanding	124.75	123.2	123.2	123.2	123.2	123.2
Working Capital	111.73	114	371.7	494.91	648.52	848.02
Book Value Per Share	8.40	8.92	10.37	11.13	11.85	11.86
Tangible Book Value	1,017	1,069	1,247	1,336	1,419	1,416
Tangible Book Value Per Share	8.15	8.68	10.12	10.84	11.52	11.49
Buildings	-	116.73	117.03	107.68	107.22	107.18
Machinery	-	224.24	221.67	206.49	204.15	196.33
Construction In Progress	-	687.59	661.51	649.46	619.86	341.8

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 1, 2026

Data Sources Report a data error